ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
7.94
-0.01 (-0.13%)
At close: Apr 28, 2026, 4:00 PM EDT
7.93
-0.01 (-0.11%)
After-hours: Apr 28, 2026, 6:14 PM EDT
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $788.42 million as of April 28, 2026. Its market cap has decreased by -39.31% in one year.
Market Cap
788.42M
Enterprise Value
711.95M
1-Year Change
-39.31%
Ranking
Category
Stock Price
$7.94
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $788.42M, an increase of 38.75%. That is a compound annual growth rate of 9.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 789.41M | -31.45% |
| Dec 31, 2025 | 1.15B | 12.32% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alto Neuroscience | 859.49M |
| MeiraGTx Holdings | 854.30M |
| Theravance Biopharma | 847.57M |
| MannKind | 833.75M |
| Arbutus Biopharma | 827.15M |
| Crescent Biopharma | 823.70M |
| Kura Oncology | 821.94M |
| SELLAS Life Sciences Group | 800.94M |